Ftse Mib
35.336,00
0,60%
DAX
20.416,27
0,76%
S&P 500
5.842,91
0,11%
NASDAQ
19.044,39
-0,23%
Bitcoin
96.530,88
0,03%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ BioCardia Inc (BCDA) BioCardia Inc (BCDA) Notizie

BioCardia Inc

BCDA
2,16
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 10:05:49
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
26/12/202420:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202420:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/12/202417:50EDGAR2Form 144 - Report of proposed sale of securities
17/12/202413:00EDGAR2Form 8-K - Current report
17/12/202413:00GLOBEBioCardia Announces Commercial Availability of Morph® DNA™..
09/12/202423:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202414:30EDGAR2Form 8-K - Current report
04/12/202414:30GLOBEBioCardia Announces Positive Consultation with Japan PMDA on..
02/12/202423:03EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
19/11/202414:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202422:05GLOBEBioCardia Reports Third Quarter 2024 Business Highlights and..
06/11/202413:00GLOBEBioCardia to Host Q3 2024 Corporate Update and Financial..
28/10/202414:00EDGAR2Form 8-K - Current report
28/10/202414:00GLOBEBioCardia Completes Phase III Randomized Double-Blind..
17/10/202403:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202403:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202403:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202403:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202403:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202403:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202403:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202403:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202403:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202414:30EDGAR2Form 8-K - Current report
18/9/202414:30GLOBEBioCardia Regains Full Compliance with Nasdaq Listing..
09/9/202422:06EDGAR2Form 8-K - Current report
09/9/202422:05GLOBEBioCardia Announces Closing of Upsized $7.2 Million Public..
07/9/202401:45EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
05/9/202418:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202418:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202418:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202418:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/9/202412:01EDGAR2Form 8-K - Current report
30/8/202423:21EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
30/8/202423:20EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
30/8/202414:00EDGAR2Form 8-K - Current report
30/8/202414:00GLOBEBioCardia Announces Pricing of Upsized $7.2 Million Public..
30/8/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
30/8/202402:09EDGAR2Form S-1MEF - Registration adding securities to prior Form..
29/8/202414:30GLOBEBioCardia Announces FDA Market Clearance of Morph® DNA™..
29/8/202412:02EDGAR2Form S-1/A - General form for registration of securities..
28/8/202423:12EDGAR2Form 8-K - Current report
21/8/202413:00EDGAR2Form 8-K - Current report
21/8/202413:00GLOBEFDA Approves CardiAMP® Heart Failure II Protocol Amendment..
13/8/202422:30GLOBEBioCardia Reports Second Quarter 2024 Business Highlights..
13/8/202422:06EDGAR2Form 8-K - Current report
13/8/202419:57EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202422:40EDGAR2Form S-1 - General form for registration of securities under..
07/8/202413:00GLOBEBioCardia to Host Q2 2024 Corporate Update and Financial..
02/8/202423:01EDGAR2Form 25-NSE - Notification filed by national security..
Apertura: Min: Max:
Chiusura: 2,16

La tua Cronologia

NASDAQ
BCDA
BioCardia
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network